Daewoong Pharma (069620)

南漢
貨幣 KRW
137,700
-3,200(-2.27%)
關閉

069620損益表

進階損益表
結束日期:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
總營收
aa.aaaa.aaaa.aaaa.aaaa.aa1,113,425.921,055,423.691,152,975.71,280,091.851,375,328.74
總營收增長
aa.aaaa.aaaa.aaaa.aaaa.aa+7.95%-5.21%+9.24%+11.03%+7.44%
收入成本
aa.aaaa.aaaa.aaaa.aaaa.aa635,992.37609,435609,226.6641,997.28688,221
毛利
aa.aaaa.aaaa.aaaa.aaaa.aa477,433.55445,988.69543,749.1638,094.57687,107.75
毛利增長
aa.aaaa.aaaa.aaaa.aaaa.aa+16.75%-6.59%+21.92%+17.35%+7.68%
毛利率%
aa.aaaa.aaaa.aaaa.aaaa.aa42.88%42.26%47.16%49.85%49.96%
其他營業支出總額
aa.aaaa.aaaa.aaaa.aaaa.aa432,746.46429,008.97455,019.78542,297.43565,990
其他營業支出總額增長
研發支出
銷售、一般、行政費用
其他營業支出
aa.aaaa.aaaa.aaaa.aaaa.aa+13.48%-0.86%+6.06%+19.18%+4.37%
aa.aaaa.aaaa.aaaa.aaaa.aa109,440.5115,217.59127,269.07163,601.58171,573.44
aa.aaaa.aaaa.aaaa.aaaa.aa311,747.62302,953.81317,558.66368,341.65383,418.02
aa.aaaa.aaaa.aaaa.aaaa.aa3,471.33,530.563,553.824,297.474,382.06
營業收入
aa.aaaa.aaaa.aaaa.aaaa.aa44,687.116,979.7288,729.3295,797.15121,117.75
營業收入增長
aa.aaaa.aaaa.aaaa.aaaa.aa+61.93%-62%+422.56%+7.97%+26.43%
EBIT利潤率%
aa.aaaa.aaaa.aaaa.aaaa.aa4.01%1.61%7.7%7.48%8.81%
淨利息費用
aa.aaaa.aaaa.aaaa.aaaa.aa-7,360.59-7,186.86-7,679.28-4,270.24-10,503.53
淨利息費用增長
aa.aaaa.aaaa.aaaa.aaaa.aa-0.57%+2.36%-6.85%+44.39%-145.97%
利息費用總額
aa.aaaa.aaaa.aaaa.aaaa.aa-10,088.05-10,609.84-10,248.27-8,405.55-13,602.9
利息和投資收益
aa.aaaa.aaaa.aaaa.aaaa.aa2,727.463,422.982,568.994,135.33,099.38
其他營業外支出總額
aa.aaaa.aaaa.aaaa.aaaa.aa-4,725.131,718.27-66,458.75-44,054.2914,848.22
EBT(不含不尋常項目)
aa.aaaa.aaaa.aaaa.aaaa.aa32,601.3911,511.1314,591.2947,472.61125,462.44
出售資產損益
aa.aaaa.aaaa.aaaa.aaaa.aa42.27,529.59-1,028.68246.4-1,221.42
其他不尋常項目總額
aa.aaaa.aaaa.aaaa.aaaa.aa-9,321.91-8,103.47-2,109.2-5,218.51-2,372.42
EBT(含不尋常項目)
aa.aaaa.aaaa.aaaa.aaaa.aa23,321.6713,559.3319,761.3738,329.66121,999.26
EBT(含不尋常項目)增長
aa.aaaa.aaaa.aaaa.aaaa.aa+3,846.31%-41.86%+45.74%+93.96%+218.29%
EBT(含不尋常項目)利潤率
aa.aaaa.aaaa.aaaa.aaaa.aa2.09%1.28%1.71%2.99%8.87%
所得稅費用
aa.aaaa.aaaa.aaaa.aaaa.aa-5,543.93-10,588.73-10,322.78-833.511,996.36
企業淨收入
aa.aaaa.aaaa.aaaa.aaaa.aa28,865.6124,148.0630,084.1539,163.17120,002.9
少數股東權益
aa.aaaa.aaaa.aaaa.aaaa.aa-6,859.68-11,394.64-5,578.413,076.351,735.78
淨收益
aa.aaaa.aaaa.aaaa.aaaa.aa22,005.9312,753.4224,505.7342,239.52121,738.68
淨收益增長
aa.aaaa.aaaa.aaaa.aaaa.aa+245.24%-42.05%+92.15%+72.37%+188.21%
淨收益率%
aa.aaaa.aaaa.aaaa.aaaa.aa1.98%1.21%2.13%3.3%8.85%
優先股及其他調整
aa.aaaa.aaaa.aaaa.aaaa.aa-----
普通股淨收入(不含特別項目)
aa.aaaa.aaaa.aaaa.aaaa.aa22,005.9312,753.4224,505.7342,239.52121,738.68
基本每股收益—持續經營增長
aa.aaaa.aaaa.aaaa.aaaa.aa2,132.181,196.12,226.873,815.9510,656.06
基本每股收益—持續經營
aa.aaaa.aaaa.aaaa.aaaa.aa+245.24%-43.9%+86.18%+71.36%+179.25%
稀釋每股收益增長—持續經營
aa.aaaa.aaaa.aaaa.aaaa.aa2,132.181,196.12,226.873,815.9510,656.06
稀釋每股收益—持續經營
aa.aaaa.aaaa.aaaa.aaaa.aa+245.24%-43.9%+86.18%+71.36%+179.25%
發行在外的普通股加權平均數
aa.aaaa.aaaa.aaaa.aaaa.aa10.3210.661111.0711.42
稀釋發行在外的普通股的加權平均數
aa.aaaa.aaaa.